Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
about
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryBroad-substrate screen as a tool to identify substrates for bacterial Gcn5-related N-acetyltransferases with unknown substrate specificityA single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regionsAccuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.Biological monitoring of carcinogens: current status and perspectives.Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysis.Role of the N-acetylation polymorphism in solithromycin metabolism.Extrahepatic Drug-Metabolizing Enzymes and Their Significance
P2860
Q26995125-CB8C35FB-34BA-4029-BA04-8DDBA8C09060Q28485785-4B10AF54-A18C-40BC-A2A5-F23295DAA350Q34414220-EE215127-1CCC-47B2-9717-C653D248BF0BQ35657155-55F105D7-4034-4CF1-8FD4-C76977A0E0F4Q35774965-C66CE5D6-1011-4434-8030-2F2090F5BC0FQ35830906-AB9A6B8E-6313-44A8-BF0F-BB31A1F032EEQ37967223-1120E9EF-3764-4ED5-A1FE-378F98A99603Q41068782-7AD77622-A3CB-4FCC-B4AF-AC50DC201A5CQ47359205-679409A2-833E-4267-9D29-4AE9DF40C455Q48123467-539DF038-85A7-4522-8151-FAD4A0CBFA16Q48129221-D17E59A6-C26A-4752-BB49-A46465993A2FQ51664167-F7D8972C-7B45-43AC-8090-18895E933F36Q55154837-0C3EA823-65D3-4807-84FC-A943E93E7BB5Q57258718-6E403C5C-E6BC-42AB-8968-91C10B872E58
P2860
Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@ast
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@en
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@nl
type
label
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@ast
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@en
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@nl
prefLabel
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@ast
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@en
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@nl
P2093
P2860
P356
P1476
Codominant expression of N-ace ...... ferase 2 in human hepatocytes.
@en
P2093
Mark A Doll
Timothy Moeller
P2860
P304
P356
10.1124/JPET.110.168567
P407
P577
2010-04-29T00:00:00Z